The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant SHR-1701 (a bifunctional anti-PD-L1/TGF-ßRII agent) combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A phase II trial.
 
Chengixn Liu
No Relationships to Disclose
 
Wei Huang
No Relationships to Disclose
 
Chengrui Fu
No Relationships to Disclose
 
Hongfu Sun
No Relationships to Disclose
 
Qian Zhao
No Relationships to Disclose
 
Changhong Zhao
Employment - Jiangsu Hengrui Pharmaceuticals
 
Xiaoyu Chen
Employment - Jiangsu Hengrui Pharmaceuticals
 
Baosheng Li
No Relationships to Disclose